Biomarkers
- The Technion
- February 5, 2024
- No comments
The technology developed by Prof. Yuval Shaked's research group was registered as a patent and is now in the process of being commercialized
- Avi Blizovsky
- January 15, 2021
- No comments
A marker developed in a new Israeli study by the University of Bar-in and applied by the start-up company Isotopia will not only determine if it is a malignant or benign tumor but also determine how aggressive it is, and all this will be done in one image and avoid a biopsy
- Dr. Moshe Nahamani
- October 2, 2019
- No comments